How Rentschler Biopharma is facing the future

May 11, 2018 How Rentschler Biopharma is facing the future

Presentation of Rentschler Biopharma's "Strategy 2025" at the Swiss Biotech Day 2018

With the words "I would like to tell you how Rentschler Biopharma is facing the future!", Frank Mathias, CEO of Rentschler Biopharma, started his inspiring presentation in the keynote session at this year's Swiss Biotech Day on May 3, 2018 in Basel. Attentively, the audience watched how Management and employees of the Swabian service provider jointly developed and launched ideas to fuel a successful future. Information from various sources, ranging from societal megatrends to interviews with experts, flowed into the development.

In the next few years, Rentschler Biopharma, guided by the "Strategy 2025", will offer new services and business models along their value chain and ensure their technological leadership through a variety of innovations. But not everything will be new. Rentschler Biopharma will continue to be an independent family business and an expert in the development and manufacture of complex and highly effective biopharmaceuticals. This was a promise Frank Mathias made his listeners.

You will find a video summary of the event, including a short interview with Federico Pollano, Senior Vice President of Business Development at Rentschler Biopharma, here.

Contact Person:
Rentschler Biopharma SE
Dr. Alexander Starnecker
Manager Company Development
communications@rentschler-biopharma.com